Related Experiment Video
Updated: Oct 12, 2025
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
671
The Year in Basic Thyroid Cancer Research.
1Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York, USA.
Thyroid : Official Journal of the American Thyroid Association
|November 22, 2021
Summary
Recent thyroid cancer research highlights advances in genetics, molecular biology, and preclinical science. These studies offer new insights into thyroid cancer pathogenesis and treatment, despite pandemic challenges.
Area of Science:
- Basic science research in thyroidology.
- Focus on thyroid cancer advancements.
Background:
- The American Thyroid Association (ATA) meeting typically showcases advances in basic, clinical, and surgical thyroidology.
- The 2021 meeting featured a special "Two Years in Thyroidology" session due to the cancellation of the 2020 meeting due to the COVID-19 pandemic.
Purpose of the Study:
- To review significant basic science research in thyroid cancer published between October 2019 and September 2021.
- To identify methodologically rigorous studies likely to impact the field of basic science research in thyroid cancer.
Main Methods:
- A PubMed electronic search was performed for original basic science research studies on thyroid cancer.
- Studies were categorized into Genetics and Genomics, Molecular Biology and Signaling, and Preclinical and Translational Science.
- Four publications were selected for discussion within each category.
Main Results:
- Selected studies explored thyroid cancer predisposition genetics and anaplastic thyroid cancer evolution genomics.
- Research covered novel molecular pathways in thyroid cancer pathogenesis.
- Innovations in imaging and therapeutics were also discussed.
Conclusions:
- Significant developments occurred in basic and translational thyroid cancer research over the past two years, despite COVID-19 pandemic challenges.
- These studies provided new insights into scientific questions and identified remaining challenges in the field.
Related Concept Videos
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:20Synthesis and Regulation of Thyroid Hormones
5.5K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.5K
01:23The Thyroid Gland
4.7K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
4.7K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:50Combination Therapies and Personalized Medicine
5.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
01:21Cancer Survival Analysis
478
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
478